President of ISOTOPE Technologies Munich AG: Nuclear medicine plays offers new technologies in the field of diagnosis and treatment

The first international business conference of manufacturers, suppliers and consumers of isotopic products (1MBA) was old in Moscow on October 1. The organizer of the conference is OJSC “ISOTOP”, the company “Radiation Technologies” of the Rosatom State Corporation. The task of the 1mba is to collect key participants in the isotopic market. During plenary meetings, scientific and business sections, issues of developing the global market for the consumption of isotopic products will be discussed; transportation of sources of ionizing radiation, production and supply of radioisotope products of industrial use; development of nuclear medicine; quality control in the production of medical devices; development in the production of medical isotopes and radiopharmaceuticals; state regulation of the circulation of isotopic products; Personnel issues for radiochemical industries. The conference will be attended by representatives of the State Corporation Rosatom, IAEA, ministries and departments of the Russian Federation, largest manufacturers of isotopic products, medical and scientific institutions.

Steffen Schuster , President of ISOTOPE TechNologies Munich AG:

I think that Russia has good prospects in the isotopes market. We, as a company operating in the field of nuclear medicine, see the possibilities for the emergence of new drugs and technologies on the world market of isotopes. Nuclear medicine plays a very large role today, as it offers new technologies in the field of diagnosis and treatment that cannot provide other areas of medicine.